REGENXBIO (RGNX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

RGNX is expected to report earnings to fall 5.80% to -129 cents per share on August 07

REGENXBIO RGNX Stock Earnings Reports
Q2'24
Est.
$-1.30
Q1'24
Missed
by $0.12
Q4'23
Missed
by $0.16
Q3'23
Beat
by $0.04
Q2'23
Missed
by $0.47
The last earnings report on May 08 showed earnings per share of -137 cents, missing the estimate of -125 cents. With 422.04K shares outstanding, the current market capitalization sits at 619.64M.
View a ticker or compare two or three
RGNX
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com